Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SANGAMO THERAPEUTICS, INC | VP, HEAD OF RESEARCH | Common Stock | 194K | $167K | $0.86 | Aug 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMO | SANGAMO THERAPEUTICS, INC | Aug 24, 2024 | 2 | -$1.03K | 4 | Aug 27, 2024 | VP, HEAD OF RESEARCH |
SGMO | SANGAMO THERAPEUTICS, INC | May 24, 2024 | 2 | -$717 | 4 | May 29, 2024 | VP, HEAD OF RESEARCH |
SGMO | SANGAMO THERAPEUTICS, INC | Feb 24, 2024 | 2 | -$5.27K | 4 | Feb 27, 2024 | VP, HEAD OF RESEARCH |
SGMO | SANGAMO THERAPEUTICS, INC | Jan 22, 2024 | 1 | $0 | 4 | Jan 24, 2024 | VP, HEAD OF RESEARCH |
SGMO | SANGAMO THERAPEUTICS, INC | Nov 25, 2023 | 1 | -$187 | 4 | Nov 28, 2023 | VP, Head of Research |
SGMO | SANGAMO THERAPEUTICS, INC | Nov 20, 2023 | 0 | $0 | 3 | Nov 28, 2023 | VP, Head of Research |